These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35241665)

  • 1. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
    Liu X; Jin S; Hu S; Li R; Pan H; Liu Y; Lai P; Xu D; Sun J; Liu Z; Gao Y; Zhao Y; Liu F; Xiao Y; Li Y; Wen Y; Chen Z; Xu B; Lin Y; Ran M; Li Q; Yang S; Li H; Tu P; Haniffa M; Teichmann SA; Bai F; Wang Y
    Nat Commun; 2022 Mar; 13(1):1158. PubMed ID: 35241665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
    Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
    Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.
    Herrera A; Cheng A; Mimitou EP; Seffens A; George D; Bar-Natan M; Heguy A; Ruggles KV; Scher JU; Hymes K; Latkowski JA; Ødum N; Kadin ME; Ouyang Z; Geskin LJ; Smibert P; Buus TB; Koralov SB
    Blood; 2021 Oct; 138(16):1456-1464. PubMed ID: 34232982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
    Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
    Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.
    Patil K; Kuttikrishnan S; Khan AQ; Ahmad F; Alam M; Buddenkotte J; Ahmad A; Steinhoff M; Uddin S
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):382-399. PubMed ID: 34906723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma.
    Nakai S; Kiyohara E; Watanabe R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma.
    Kume M; Kiyohara E; Matsumura Y; Koguchi-Yoshioka H; Tanemura A; Hanaoka Y; Taminato M; Tashima H; Tomita K; Kubo T; Watanabe R; Fujimoto M
    Front Immunol; 2021; 12():651048. PubMed ID: 33859643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations.
    Ren J; Qu R; Rahman NT; Lewis JM; King ALO; Liao X; Mirza FN; Carlson KR; Huang Y; Gigante S; Evans B; Rajendran BK; Xu S; Wang G; Foss FM; Damsky W; Kluger Y; Krishnaswamy S; Girardi M
    Blood Adv; 2023 Feb; 7(3):445-457. PubMed ID: 35947128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic landscape of cutaneous T cell lymphoma.
    Choi J; Goh G; Walradt T; Hong BS; Bunick CG; Chen K; Bjornson RD; Maman Y; Wang T; Tordoff J; Carlson K; Overton JD; Liu KJ; Lewis JM; Devine L; Barbarotta L; Foss FM; Subtil A; Vonderheid EC; Edelson RL; Schatz DG; Boggon TJ; Girardi M; Lifton RP
    Nat Genet; 2015 Sep; 47(9):1011-9. PubMed ID: 26192916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.
    Takahashi Y; Takata K; Kato S; Sato Y; Asano N; Ogino T; Hashimoto K; Tashiro Y; Takeuchi S; Masunari T; Hiramatsu Y; Maeda Y; Tanimoto M; Yoshino T
    Cancer Sci; 2014 Jul; 105(7):912-23. PubMed ID: 24815502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
    Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
    J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.
    Licht P; Mailänder V
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
    Yumeen S; Girardi M
    Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma.
    Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
    Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.